Journal of Hematology & Oncology

official impact factor 2.93

Open Access Highly Access Review

Angiogenesis inhibitors in the treatment of prostate cancer

Clara Hwang* and Elisabeth I Heath

Journal of Hematology & Oncology 2010, 3:26 doi:10.1186/1756-8722-3-26

No comments have yet been made on this article.

Post a comment